Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
about
Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway.NF-κB signaling maintains the survival of cadmium-exposed human renal glomerular endothelial cells.Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway.Low-Dose Cadmium Upregulates VEGF Expression in Lung Adenocarcinoma Cells.Dose dependent effects of cadmium on tumor angiogenesis.Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function.Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells.Loss of Complement Factor H in Plasma Increases Endothelial Cell MigrationDirect Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis.Differential sex-specific effects of oxygen toxicity in human umbilical vein endothelial cells.Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.Dihydroartemisinin enhances VEGFR1 expression through up-regulation of ETS-1 transcription factor
P2860
Q28066236-20C9DC1A-5DFE-4F1B-BA16-F36BEB93DCE7Q35737422-073D00DE-4EE5-4876-A2EC-60AB051E426FQ37070186-092766C6-CB72-48CC-A93E-0B2F84F111E2Q37204589-981171B5-CB0D-4625-B8E4-0384FD7B27C7Q38837495-D90F6E1F-7451-454A-A486-445D5DC601E6Q39226994-DAE78A3B-7BA2-4ED9-B908-A0EB8DD9225DQ40040729-DB66F1E1-DF9D-4416-9ABE-C4FE353B5D25Q41406149-E30333C3-FA62-43A2-AD93-24E2AB98FA65Q41440969-1810FF44-3F56-4121-87FF-31090142D43FQ46323337-B1CB9012-305E-48E2-A234-F512D024C76AQ47823751-7C4D5DC2-D475-4BBA-9E7C-077181887D58Q47940565-C60D65DF-8BB2-4F01-BD96-F26C4A8E648EQ57116380-53235E72-F07C-445C-BFCF-2793D8DB232F
P2860
Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Dihydroartemisinin targets VEG ...... cells to inhibit angiogenesis.
@en
type
label
Dihydroartemisinin targets VEG ...... cells to inhibit angiogenesis.
@en
prefLabel
Dihydroartemisinin targets VEG ...... cells to inhibit angiogenesis.
@en
P2093
P2860
P1476
Dihydroartemisinin targets VEG ...... cells to inhibit angiogenesis.
@en
P2093
Changsheng Li
Fengyun Dong
Xianming Deng
Zhiqun Cao
P2860
P304
P356
10.4161/15384047.2014.955728
P577
2014-01-01T00:00:00Z